MissionIR's  Instablog

Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
My blog:
MissionIR Blog
  • Rexahn Pharmaceuticals, Inc. (RNN) Licenses Innovative Oncology Drug Delivery Platform 0 comments
    Jul 17, 2013 4:09 PM | about stocks: RNN

    Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing best-in-class therapeutics for the treatment of cancer. The company also has developed proprietary drug discovery platform technologies in the areas of Nano-Polymer-Drug Conjugate Systems (NPDCS), nano-medicines, 3D-GOLD, and TIMES.

    The company reported today that it has signed an exclusive license agreement with the University of Maryland, Baltimore, for its NPDCS platform. It is a result of initial funding through a Maryland Industrial Partnership (NASDAQ:MIPS) award. The awards are intended to foster relationships between Maryland universities and industries.

    This particular technology targets the delivery of currently marketed chemotherapeutic agents directly into cancerous tumors. Rexahn's NPDCS platform combines existing chemotherapeutic agents with a proprietary polymer carrier that contains a signaling component.

    This approach reduces the levels of anti-cancer agents circulating in the body, which substantially lowers the risk possible adverse side effects while maximizing anti-tumor activity. Rexahn's delivery method has been shown to result in increased efficacy and reduced toxicity and beats other current delivery methods.

    For additional information about Rexahn Pharmaceuticals, please visit www.rexahn.com

    Please see disclaimer on the MissionIR website

    Stocks: RNN
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.